BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33417954
Number of visits today
8730
Number of downloads
16607577
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yang M, Olaoba OT, Zhang C, Kimchi ET, Staveley-o’carroll KF, Li G. Cancer Immunotherapy and Delivery System: An Update. Pharmaceutics 2022;14:1630. [DOI: 10.3390/pharmaceutics14081630] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Desai N, Hasan U, K J, Mani R, Chauhan M, Basu SM, Giri J. Biomaterial-based Platforms for Modulating Immune Components against Cancer and Cancer Stem Cells. Acta Biomater 2023:S1742-7061(23)00130-7. [PMID: 36907233 DOI: 10.1016/j.actbio.2023.03.004] [Reference Citation Analysis]
2 Kang Y, Li S. Nanomaterials: Breaking through the bottleneck of tumor immunotherapy. Int J Biol Macromol 2023;230:123159. [PMID: 36610572 DOI: 10.1016/j.ijbiomac.2023.123159] [Reference Citation Analysis]
3 Fang L, Tian W, Zhang C, Wang X, Li W, Zhang Q, Zhang Y, Zheng J. Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma. Pharmacol Res 2023;189:106701. [PMID: 36796464 DOI: 10.1016/j.phrs.2023.106701] [Reference Citation Analysis]
4 Olaoba OT, Ayinde KS, Lateef OM, Akintubosun MO, Lawal KA, Adelusi TI. Is the new angel better than the old devil? Challenges and opportunities in CD47- SIRPα-based cancer therapy. Crit Rev Oncol Hematol 2023;184:103939. [PMID: 36774991 DOI: 10.1016/j.critrevonc.2023.103939] [Reference Citation Analysis]
5 Ruff SM, Shannon AH, Beane JD, Pawlik TM. Highlighting novel targets in immunotherapy for liver cancer. Expert Rev Gastroenterol Hepatol 2022;16:1029-41. [PMID: 36404729 DOI: 10.1080/17474124.2022.2150841] [Reference Citation Analysis]
6 Bukhari I, Zhang Y, Thorne RF, Mi Y. Editorial: Complexity of tumor microenvironment: A major culprit in cancer development. Front Endocrinol 2022;13:1059885. [DOI: 10.3389/fendo.2022.1059885] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345